Filter posts

The New Republic: We are Entering the Age of Alzheimer’s

The New Republic this week published a lengthy, powerful piece by Kent Russell on Alzheimer’s. …

Pitts Sounds off on Biosimilar Naming

This week, the Food and Drug Law Institute published a white paper – Biosimilar Nomenclature: …

4 Benefits of Plant-Made Pharmaceuticals

For centuries, plants have served as a natural source of treatments and therapies. New advances …

ALS Ice Bucket Challenge Brings Attention to the Need For Private Funding

The ALS Ice Bucket Challenge – the social media phenomenon in which people post videos …

WSJ Editorial: The Medical Innovation Threat

An editorial in today’s Wall Street Journal looks at the rising threat the American insurance industry’s …

Promising vaccine companies set to take the stage at BIO Investor Forum

It is no secret that vaccines are a hot space in biotech right now, and …

AP: Groups Claim Insurance Discrimination

In this August 18 article, Ricardo Alonso-Zaldivar highlights assertions by patient groups that new insurance …

Docs to FDA: Biosimilars should have different names than branded drugs

Yesterday, Fierce Biotech highlighted a letter written by more than 10 medical associations and 20 individual specialists …

National Immunization Awareness Month

August is National Immunization Awareness Month, providing a reminder of the importance of proper vaccination …

Seattle Times Commentary: New Approaches Needed to Fight Ebola

In the Seattle Times this week, BIO Ventures for Global Health President Jennifer Dent offered …